General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview


  • Enterococcus massiliensis is a Gram-positive, non-spore-forming, facultatively anaerobic, motile, oval-shaped bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. The DNA G+C content is 39.6%. Enterococcus massiliensis is probably a rare gut coloniser. (LePage2016)



  • This organism has been recovered from the faeces of a healthy volunteer. Pathogenicity status unknown, or very unlikely to be pathogenic. A possible gut commensal.

  • GENERAL CHARACTERISTICS (LePage2016);
    Character Response
  • Substrates hydrolysed or digested:
  • aesculin;
  • 🌡
  • Temperature tolerance:
  • grows at 25℃; Grows optimally at 37℃.
  • H+
  • Acid from carbohydrates usually produced:
  • fructose; glucose; mannose; ribose; xylose; raffinose; trehalose; N-Ac glucosamine;
  • Active enzymes:
  • alkaline phosphatase; acid phosphatase; esterase C4; esterase lipase C8; β-galactosidase; Leu arylamidase;

  • SPECIAL FEATURES (LePage2016);
    Character Response
  • Haemolysis:
  • absent
  • Pigments:
  • not produced

  • RESPONSE TO ANTIBIOTICS (LePage2016);
    Class Active Resistant
  • Penicillins:
  • oxacillin; penicillin G;
  • Cephalosporins:
  • cefoxitin;
  • Macrolides:
  • pristinamycin;
  • erythromycin;
  • Tetracyclines:
  • doxycycline;
  • Quinolines:
  • ciprofloxacin;
  • Aminoglycosides:
  • gentamicin;
  • Polypep/ketides:
  • rifampicin;
  • Heterocycles:
  • fosfomycin; trimethoprim-sulfamethoxazole;
  • Vancomycins:
  • vancomycin; teicoplanin;
  • Miscellaneous antibiotics:
  • linezolid; pristinamycin;
  • clindamycin;

  • Details


    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Firmicutes Class:  Bacilli Order:  Lactobacillales Family:  Enterococcaceae Genus:  Enterococcus Gram stain:  + O2 Relation.:  facultatively anaerobic Spore:  No spore Motility:  Swimming Morphology:  Oval-shaped Pigment:  neg
    Health:  Unknown
    Source:  the faeces of a healthy volunteer
    DNA G+C(%):  39.6
    Opt. T:  37℃
    Lower T(℃):  25(+)
    Aesculin:  +

    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    Fructose:  + Glucose:  + Mannose:  + Ribose:  + Sorbose:  neg Xylose:  + Trehalose:  + Mannitol:  neg Sorbitol:  neg NAc-α-GA:  +

    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  neg Catalase:  neg Ac-β-glcamnd:  neg β-Galactosidase:  + LeuAA:  + AlkalineP:  + AcidP:  + Esterase(C4):  + EstLip(C8):  +

    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    Pigment:  neg

    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    oxacillin:  Res
    penicillin_G:  Res
    cefoxitin:  Res
    gentamicin:  Sens
    erythromycin:  Res
    pristinamycin:  Sens
    linezolid:  Sens
    ciprofloxacin:  Sens
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    doxycycline:  Sens
    teicoplanin:  Sens
    vancomycin:  Sens
    rifampicin:  Sens
    fosfomycin:  Res
    SXT:  Res
    clindamycin:  Res

    References


    SPECIFIC REFERENCES FOR ENTEROCOCCUS MASSILIENSIS
  • LePage2016 - Noncontiguous finished genome sequence and description of Enterococcus massiliensis sp. nov.
  • ...............................
  • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR ENTEROCOCCUS MASSILIENSIS
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • ...............................